Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation

FASEB Journal

Volumn 21, Issue 8, 2007, Pages 1751-1758

  Gavins, Felicity N E ^a   Dalli, Jesmond ^a   Flower, Roderick J ^a   Granger, D Neil ^b   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Endogenous anti inflammation; Intravital microscopy

Indexed keywords

ALANYLMETHIONYLVALYLSERYLGLUTAMYLPHENYLALANYLLEUCYLLYSYL GLUTAMINYLALANYLTRYPTOPHYLPHENYLALANYLISOLEUCYLGLUTAMYLASPARAGINYL GLUTAMYLGLUTAMYLGLUTAMINYLGLUTAMYLTYROSYLVALYLGLUTAMINYLTHREONYLVALYLLYSINE; ANNEXIN; FORMYLPEPTIDE RECEPTOR; PEPTIDE; RECOMBINANT ANNEXIN 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INFARCTION; BRAIN MICROCIRCULATION; BRAIN PROTECTION; CELL ADHESION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; GENETIC TRANSFECTION; HOMEOSTASIS; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ANNEXIN A1; BRAIN; CEREBROVASCULAR CIRCULATION; HOMEOSTASIS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; MICE; MICE, KNOCKOUT; MICROCIRCULATION; PEPTIDES; RECOMBINANT PROTEINS;

MUS; MUS MUSCULUS;

EID: 34249796092     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-7842com     Document Type: Article

References (50)

1. Morgan, L., and Humphries, S. E. (2005) The genetics of stroke. Curr. Opin. Lipidol. 16, 193-199
2. Frijns, C. J., and Kappelle, L. J. (2002) Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 33, 2115-2122
3. Matsumoto, T., Yokoi, K., Mukaida, N., Harada, A., Yamashita, J., Watanabe, Y., and Matsushima, K. (1997) Pivotal role of interleukin-8 in the acute respiratory distress syndrome and cerebral reperfusion injury. J. Leukocyte Biol. 62, 581-587
4. Granger, D. N. (1999) Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation 6, 167-178
5. Ishikawa, M., Vowinkel, T., Stokes, K. Y., Arumugam, T. V., Yilmaz, G., Nanda, A., and Granger, D. N. (2005) CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation 111, 1690-1696
6. Minghetti, L., and Levi, G. (1998) Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Progress Neurobiol. 54, 99-125
7. Frizzell, J. P. (2005) Acute stroke: pathophysiology, diagnosis, and treatment. AACN Clin. Issues. 16, 421-440; quiz 597-428
8. Gilroy, D. W., Lawrence, T., Perretti, M., and Rossi, A. G. (2004) Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug. Discov. 3, 401-416
9. Serhan, C. N., and Savill, J. (2005) Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191-1197
10. Perretti, M. (2003) The annexin 1 receptor(s): is the plot unravelling? Trends Pharmacol. Sci. 24, 574-579
11. Yang, Y., Hutchinson, P., and Morand, E. F. (1999) Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis. Arthritis. Rheum. 42, 1538-1544
12. Gavins, F. N., Yona, S., Kamal, A. M., Flower, R. J., and Perretti, M. (2003) Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 101, 4140-4147
13. Gavins, F. N., Kamal, A. M., D'Amico, M., Oliani, S. M., and Perretti, M. (2005) Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct. FASEB J. 19, 100-102
14. Perretti, M., Chiang, N., La, M., Fierro, I. M., Marullo, S., Getting, S. J., Solito, E., and Serhan, C. N. (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A(4) receptor. Nat. Med. 8, 1296-1302
15. Maderna, P., Yona, S., Perretti, M., and Godson, C. (2005) Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac2-26. J. Immunol. 174, 3727-3733
16. Babbin, B. A., Lee, W. Y., Parkos, C. A., Winfree, L. M., Akyildiz, A., Perretti, M., and Nusrat, A. (2006) Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J. Biol. Chem. 281, 19588-19599
17. Relton, J. K., Strijbos, P. J. L. M., O'Shaughnessy, C. T., Carey, F., Forder, R. A., Tilders, F. J., and Rothwell, N. J. (1991) Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. J. Exp. Med. 174, 305-310
18. Young, K. A., Hirst, W. D., Solito, E., and Wilkin, G. P. (1999) De novo expression of lipocortin-1 in reactive microglia and astrocytes in kainic acid lesioned rat cerebellum. Glia 26, 333-343
19. Hannon, R., Croxtall, J. D., Getting, S. J., Roviezzo, F., Yona, S., Paul-Clark, M. J., Gavins, F. N., Perretti, M., Morris, J. F., Buckingham, J. C., and Flower, R. J. (2003) Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J. 17, 253-255
20. Gao, J. L., Lee, E. J., and Murphy, P. M. (1999) Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J. Exp. Med. 189, 657-662
21. Ishikawa, M., Cooper, D., Russell, J., Salter, J. W., Zhang, J. H., Nanda, A., and Granger, D. N. (2003) Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation. Stroke 34, 1777-1782
22. Hayhoe, R. P., Kamal, A. M., Solito, E., Flower, R. J., Cooper, D., and Perretti, M. (2006) Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 107, 2123-2130
23. D'Amico, M., Di Filippo, C., La, M., Solito, E., McLean, P. G., Flower, R. J., Oliani, S. M., and Perretti, M. (2000) Lipocortin 1 reduces myocardial ischaemia-reperfusion injury by affecting local leukocyte recruitment. FASEB J. 14, 1867-1869
24. Wang, Z. G., and Ye, R. D. (2002) Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice. Gene 299, 57-63
25. Chiang, N., Takano, T., Arita, M., Watanabe, S., and Serhan, C. N. (2003) A novel rat lipoxin A4 receptor that is conserved in structure and function. Br. J. Pharmacol. 139, 89-98
26. Damazo, A. S., Yona, S., D'Acquisto, F., Flower, R. J., Oliani, S. M., and Perretti, M. (2005) Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am. J. Pathol. 166, 1607-1617
27. Chatterjee, B. E., Yona, S., Rosignoli, G., Young, R. E., Nourshargh, S., Flower, R. J., and Perretti, M. (2005) Annexin 1 deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. J. Leukoc. Biol. 78, 639-646
28. Getting, S. J., Flower, R. J., and Perretti, M. (1997) Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1. Br. J. Pharmacol. 120, 1075-1082
29. Ernst, S., Lange, C., Wilbers, A., Goebeler, V., Gerke, V., and Rescher, U. (2004) An annexin 1 N-terminal Peptide activates leukocytes by triggering different members of the formyl Peptide receptor family. J. Immunol. 172, 7669-7676
30. Chiang, N., Serhan, C. N., Dahlen, S. E., Drazen, J. M., Hay, D. W., Rovati, G. E., Shimizu, T., Yokomizo, T., and Brink, C. (2006) The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58, 463-487
31. Le, Y., Murphy, P. M., and Wang, J. M. (2002) Formyl-peptide receptors revisited. Trends Immunol. 23, 541-548
32. Kenakin, T. (2002) Efficacy at g protein-coupled receptors. Nature Rev. (Drug Discovery) 1, 103-110
33. Ying, G., Iribarren, P., Zhou, Y., Gong, W., Zhang, N., Yu, Z. X., Le, Y., Cui, Y., and Wang, J. M. (2004) Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J. Immunol. 172, 7078-7085
34. Hartt, J. K., Barish, G., Murphy, P. M., and Gao, J. L. (1999) N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N- formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR. J. Exp. Med. 190, 741-747
35. Hachicha, M., Pouliot, M., Petasis, N. A., and Serhan, C. N. (1999) Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. J. Exp. Med. 189, 1923-1930
36. Kieran, N. E., Maderna, P., and Godson, C. (2004) Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease. Kidney. Int. 65, 1145-1154
37. Chiang, N., Arita, M., and Serhan, C. N. (2005) Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins. Leukot. Essent. Fatty Acids 73, 163-177
38. Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N., and Bazan, N. G. (2004) Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 101, 8491-8496
39. Wada, K., Arita, M., Nakajima, A., Katayama, K., Kudo, C., Kamisaki, Y., and Serhan, C. N. (2006) Leukotriene B4 and lipoxin A4 are regulatory signals for neural stem cell proliferation and differentiation. FASEB J. 20, 1785-1792
40. Coméra, C., and Russo-Marie, F. (1995) Glucocorticoid-induced annexin I secretion by monocytes and peritoneal leukocytes. Br. J. Pharmacol. 115, 1043-1047
41. Su, S. B., Gong, W., Gao, J. L., Shen, W., Murphy, P. M., Oppenheim, J. J., and Wang, J. M. (1999) A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189, 395-402
42. Hughes, P. M., Allegrini, P. R., Rudin, M., Perry, V. H., Mir, A. K., and Wiessner, C. (2002) Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J. Cereb. Blood Flow Metab. 22, 308-317
43. Lucas, S. M., Rothwell, N. J., and Gibson, R. M. (2006) The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147. Suppl. 1, S232-240
44. Minami, M., and Satoh, M. (2003) Chemokines and their receptors in the brain: pathophysiological roles in ischemic brain injury. Life Sci. 74, 321-327
45. Yona, S., Buckingham, J. C., Perretti, M., and Flower, R. J. (2004) Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophages. Br. J. Pharmacol. 142, 890-898
46. Yona, S., Heinsbroek, S. E., Peiser, L., Gordon, S., Perretti, M., and Flower, R. J. (2006) Impaired phagocytic mechanism in annexin 1 null macrophages. Br. J. Pharmacol.
47. Minghetti, L., Nicolini, A., Polazzi, E., Greco, A., Perretti, M., Parente, L., and Levi, G. (1999) Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase by lipocortin 1. Br. J. Pharmacol. 126, 1307-1314
48. Knott, C., Stern, G., and Wilkin, G. P. (2000) Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol. Cell Neurosci. 16, 724-739
49. Liu, N., Han, S., Lu, P. H., and Xu, X. M. (2004) Upregulation of annexins I, II, and V after traumatic spinal cord injury in adult rats. J. Neurosci. Res. 77, 391-401
50. Gidday, J. M. (2006) Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 7, 437-448